Entera Bio (ENTX) Free Cash Flow (QoQ) (2021 - 2026)
Entera Bio (ENTX) Free Cash Flow (QoQ) (2021 - 2026) Analysis & Trends
Peer Comparison
| # |
Company |
Market Cap |
Enterprise Value |
Gross Profit (Qtr) |
| 1 |
Alterity Therapeutics |
719,706.53 Bn |
719,706.50 Bn |
- |
| 2 |
Belite Bio |
55,800.00 Bn |
55,800.00 Bn |
- |
| 3 |
Quantum Biopharma |
18,182.30 Bn |
18,182.29 Bn |
- |
| 4 |
Legend Biotech |
3,154.00 Bn |
3,153.71 Bn |
242.10 Mn |
| 5 |
Akari Therapeutics |
1,844.30 Bn |
1,844.29 Bn |
- |
| 6 |
Evaxion A |
1,567.96 Bn |
1,567.94 Bn |
- |
| 7 |
Psyence Biomedical |
251.43 Bn |
251.42 Bn |
- |
| 8 |
Vertex Pharmaceuticals |
112.56 Bn |
105.31 Bn |
2.59 Bn |
| 9 |
Abivax |
94.37 Bn |
94.37 Bn |
- |
| 10 |
Entera Bio |
56.59 Mn |
52.45 Mn |
- |
| Date | Value |
|---|
| Mar 31, 2026 |
-66.13% |
| Dec 31, 2025 |
26.92% |
| Sep 30, 2025 |
-53.31% |
| Jun 30, 2025 |
-17.56% |
| Mar 31, 2025 |
3.95% |
| Dec 31, 2024 |
31.75% |
| Sep 30, 2024 |
-61.35% |
| Jun 30, 2024 |
28.30% |
| Mar 31, 2024 |
28.99% |
| Dec 31, 2023 |
-71.93% |
| Sep 30, 2023 |
2.24% |
| Jun 30, 2023 |
3.70% |
| Mar 31, 2023 |
19.56% |
| Dec 31, 2022 |
29.85% |
| Sep 30, 2022 |
-0.88% |
| Jun 30, 2022 |
40.89% |
| Mar 31, 2022 |
-90.92% |
| Dec 31, 2021 |
-19.19% |
| Sep 30, 2021 |
0.24% |
| Jun 30, 2021 |
8.62% |
